| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.25e-07 | 25 | 110 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SP1 NRG1 DDX17 UBQLN2 PCLAF HIPK1 DLGAP4 ZMYND8 KDM3B HIPK2 MED13L MED1 PIAS1 FBXO38 GAS2L1 ARID1B NCOA1 SMARCE1 TAB1 ALDOB BAG6 MED12 MED13 NUP153 | 2.76e-07 | 1356 | 110 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.39e-07 | 27 | 110 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | chromatin binding | DDX17 PCLAF BCAS3 KDM3B POU2F1 MLLT10 MED1 ONECUT1 ARID1B ATXN7 NFE2L1 NCOA1 KMT2A SMARCE1 MLLT6 MED12 NUP153 | 5.90e-07 | 739 | 110 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NRG1 DDX17 HIPK1 ZMYND8 KDM3B HIPK2 MED13L MED1 PIAS1 ARID1B NCOA1 SMARCE1 MED12 MED13 | 2.56e-06 | 562 | 110 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | signal sequence binding | 8.89e-06 | 51 | 110 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NRG1 DDX17 UBQLN2 HIPK1 ZMYND8 KDM3B HIPK2 MED13L MED1 PIAS1 FBXO38 GAS2L1 ARID1B NCOA1 SMARCE1 MED12 MED13 NUP153 | 6.12e-05 | 1160 | 110 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 1.25e-04 | 18 | 110 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.79e-04 | 4 | 110 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.75e-04 | 303 | 110 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 3.57e-04 | 61 | 110 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP1 BCAS3 ZMYND8 HIPK2 MED1 PIAS1 NCOA1 KMT2A SMARCE1 MED12 MED13 | 3.69e-04 | 582 | 110 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 5.35e-04 | 29 | 110 | 3 | GO:0035035 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 5.96e-04 | 187 | 110 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.60e-04 | 34 | 110 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 1.91e-03 | 12 | 110 | 2 | GO:0005049 | |
| GeneOntologyMolecularFunction | nucleosome binding | 2.12e-03 | 98 | 110 | 4 | GO:0031491 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.17e-03 | 417 | 110 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | SP1 BCAS3 ZMYND8 HIPK2 MED1 PIAS1 NCOA1 KMT2A SMARCE1 MED12 MED13 | 2.93e-03 | 753 | 110 | 11 | GO:0008134 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ONECUT2 SP1 DDX17 BCAS3 PPP1R12A ZMYND8 HIPK2 POU2F1 SIX4 MLLT10 MED1 ONECUT1 AKAP8L ATXN7 NFE2L1 RNF10 NCOA1 LRP6 KMT2A MLLT6 ZFHX3 MED12 MED13 | 9.47e-07 | 1390 | 110 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | axis elongation | 1.72e-06 | 38 | 110 | 5 | GO:0003401 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 2.21e-06 | 18 | 110 | 4 | GO:0006999 | |
| GeneOntologyBiologicalProcess | embryonic retina morphogenesis in camera-type eye | 2.92e-06 | 6 | 110 | 3 | GO:0060059 | |
| GeneOntologyBiologicalProcess | nucleus organization | 3.62e-06 | 170 | 110 | 8 | GO:0006997 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 4.06e-06 | 45 | 110 | 5 | GO:0031076 | |
| GeneOntologyBiologicalProcess | lens induction in camera-type eye | 5.09e-06 | 7 | 110 | 3 | GO:0060235 | |
| GeneOntologyBiologicalProcess | respiratory system development | 5.49e-06 | 305 | 110 | 10 | GO:0060541 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.26e-05 | 96 | 110 | 6 | GO:0006405 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.28e-05 | 145 | 110 | 7 | GO:0051028 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 2.45e-05 | 32 | 110 | 4 | GO:0048596 | |
| GeneOntologyBiologicalProcess | RNA transport | 4.29e-05 | 175 | 110 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 4.29e-05 | 175 | 110 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | embryonic organ development | SP1 EYA4 HIPK1 ROR2 HIPK2 SIX4 MED1 TULP3 NCOA1 LRP6 KMT2A MED12 | 4.55e-05 | 561 | 110 | 12 | GO:0048568 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 4.77e-05 | 178 | 110 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 4.92e-05 | 38 | 110 | 4 | GO:0048048 | |
| GeneOntologyBiologicalProcess | nuclear export | 6.09e-05 | 185 | 110 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | developmental induction | 6.66e-05 | 41 | 110 | 4 | GO:0031128 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 7.86e-05 | 16 | 110 | 3 | GO:0071697 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 7.86e-05 | 16 | 110 | 3 | GO:0060788 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SP1 EYA4 HIPK1 ROR2 HIPK2 POU2F1 SIX4 MED1 TULP3 PHLDB1 NCOA1 LRP6 MED12 | 1.10e-04 | 713 | 110 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.11e-04 | 351 | 110 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 1.14e-04 | 18 | 110 | 3 | GO:0071696 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ONECUT2 SP1 NRG1 SPRY1 CDSN EYA4 HIPK1 ROR2 MUC19 HIPK2 POU2F1 SIX4 MED1 TULP3 LRP6 TAB1 CDH2 MED12 | 1.27e-04 | 1269 | 110 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | RNA localization | 1.65e-04 | 217 | 110 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 1.68e-04 | 291 | 110 | 8 | GO:0032984 | |
| GeneOntologyBiologicalProcess | nuclear transport | PPP1R12A NUP214 NUP42 MED1 POM121C AKAP8L POM121 POM121B NUP153 | 1.93e-04 | 378 | 110 | 9 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | PPP1R12A NUP214 NUP42 MED1 POM121C AKAP8L POM121 POM121B NUP153 | 1.93e-04 | 378 | 110 | 9 | GO:0006913 |
| GeneOntologyBiologicalProcess | positive regulation of ERAD pathway | 2.11e-04 | 22 | 110 | 3 | GO:1904294 | |
| GeneOntologyBiologicalProcess | branch elongation of an epithelium | 2.11e-04 | 22 | 110 | 3 | GO:0060602 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 2.28e-04 | 103 | 110 | 5 | GO:0002088 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.49e-04 | 105 | 110 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | epithelium development | ONECUT2 NRG1 SPRY1 CDSN PPP1R12A ROR2 GDF6 SIX4 HRNR MED1 KRT79 ONECUT1 TULP3 KRT75 NFE2L1 CD24 LRP6 CDH2 MED12 | 2.66e-04 | 1469 | 110 | 19 | GO:0060429 |
| GeneOntologyBiologicalProcess | olfactory placode morphogenesis | 2.79e-04 | 5 | 110 | 2 | GO:0071699 | |
| GeneOntologyBiologicalProcess | olfactory placode development | 2.79e-04 | 5 | 110 | 2 | GO:0071698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density protein 95 clustering | 2.79e-04 | 5 | 110 | 2 | GO:1902897 | |
| GeneOntologyBiologicalProcess | olfactory placode formation | 2.79e-04 | 5 | 110 | 2 | GO:0030910 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 3.62e-04 | 247 | 110 | 7 | GO:0009952 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.80e-04 | 249 | 110 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 3.93e-04 | 27 | 110 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | axis elongation involved in somitogenesis | 4.17e-04 | 6 | 110 | 2 | GO:0090245 | |
| GeneOntologyBiologicalProcess | lens morphogenesis in camera-type eye | 4.39e-04 | 28 | 110 | 3 | GO:0002089 | |
| GeneOntologyBiologicalProcess | regulation of ERAD pathway | 4.87e-04 | 29 | 110 | 3 | GO:1904292 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 5.07e-04 | 343 | 110 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 5.07e-04 | 343 | 110 | 8 | GO:0071559 | |
| GeneOntologyBiologicalProcess | pattern specification process | 5.12e-04 | 526 | 110 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immune response to tumor cell | 5.82e-04 | 7 | 110 | 2 | GO:0002842 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 6.27e-04 | 195 | 110 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.34e-04 | 445 | 110 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 6.57e-04 | 273 | 110 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | 6.65e-04 | 448 | 110 | 9 | GO:0048872 | |
| GeneOntologyBiologicalProcess | import into nucleus | 7.35e-04 | 201 | 110 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ONECUT2 NRG1 SPRY1 CDSN PPP1R12A HRNR MED1 KRT79 ONECUT1 KRT75 NFE2L1 CD24 CDH2 | 7.41e-04 | 870 | 110 | 13 | GO:0030855 |
| GeneOntologyBiologicalProcess | gland development | 8.07e-04 | 558 | 110 | 10 | GO:0048732 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 8.14e-04 | 136 | 110 | 5 | GO:0045445 | |
| GeneOntologyBiologicalProcess | response to growth factor | DOCK3 ONECUT2 SPRY1 ROR2 GDF6 HIPK2 MED1 ONECUT1 UBE2O KMT2A ZFHX3 TAB1 RNF111 | 8.49e-04 | 883 | 110 | 13 | GO:0070848 |
| GeneOntologyBiologicalProcess | mesenchyme development | 8.61e-04 | 372 | 110 | 8 | GO:0060485 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | EYA4 ZMYND8 RSF1 KDM3B HIPK2 MED1 PIAS1 EZHIP ARID1B NCOA1 KMT2A SMARCE1 MLLT6 BAG6 | 8.61e-04 | 999 | 110 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 9.90e-04 | 9 | 110 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | regulation of store-operated calcium channel activity | 9.90e-04 | 9 | 110 | 2 | GO:1901339 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.05e-03 | 144 | 110 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.05e-03 | 144 | 110 | 5 | GO:0043244 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.05e-03 | 296 | 110 | 7 | GO:0048762 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.09e-03 | 38 | 110 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.11e-03 | 482 | 110 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | keratinization | 1.21e-03 | 87 | 110 | 4 | GO:0031424 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.32e-03 | 89 | 110 | 4 | GO:1901880 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | INTS12 RSF1 KDM3B HIPK2 POU2F1 NUP214 NUP42 MED13L MED1 POM121C ARID1B POM121 UBAP2L ATXN7 NCOA1 KMT2A SMARCE1 SRRM2 POM121B MED12 MED13 NUP153 AFF4 | 7.56e-07 | 1377 | 111 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore | 1.65e-05 | 101 | 111 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.54e-05 | 109 | 111 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | chromatin | ONECUT2 SP1 POU6F2 BCAS3 ZMYND8 RSF1 KDM3B POU2F1 SIX4 MED1 RFX1 ONECUT1 PIAS1 AKAP8L ARID1B ATXN7 NFE2L1 NCOA1 SMARCE1 ZFHX3 AFF4 | 3.01e-05 | 1480 | 111 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | mediator complex | 4.34e-05 | 37 | 111 | 4 | GO:0016592 | |
| GeneOntologyCellularComponent | CKM complex | 2.77e-04 | 5 | 111 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | PML body | 5.45e-04 | 125 | 111 | 5 | GO:0016605 | |
| GeneOntologyCellularComponent | nuclear body | DDX17 HIPK1 OBSCN HIPK2 PIAS1 AKAP8L UBE2O SBF1 SLTM ZFHX3 TAB1 SRRM2 RNF111 | 1.00e-03 | 903 | 111 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | bBAF complex | 1.22e-03 | 10 | 111 | 2 | GO:0140092 | |
| HumanPheno | Thin upper lip vermilion | ROR2 KDM3B CILK1 ARID1B UBAP2L SLC9A7 KMT2A SMARCE1 SRRM2 CDH2 MED12 MED13 AFF4 | 6.67e-07 | 339 | 39 | 13 | HP:0000219 |
| HumanPheno | Thin lips | ROR2 KDM3B CILK1 ARID1B UBAP2L SLC9A7 KMT2A SMARCE1 SRRM2 CDH2 MED12 MED13 AFF4 | 6.67e-07 | 339 | 39 | 13 | HP:0000213 |
| HumanPheno | Abnormality of upper lip vermillion | ROR2 KDM3B CILK1 ARID1B UBAP2L SLC9A7 KMT2A SMARCE1 CAMSAP1 SRRM2 CDH2 MED12 MED13 AFF4 | 3.97e-06 | 464 | 39 | 14 | HP:0011339 |
| HumanPheno | Thin vermilion border | ROR2 KDM3B CILK1 ARID1B UBAP2L SLC9A7 KMT2A SMARCE1 SRRM2 CDH2 MED12 MED13 AFF4 | 1.05e-05 | 433 | 39 | 13 | HP:0000233 |
| Domain | PHD | 4.02e-06 | 75 | 105 | 6 | PF00628 | |
| Domain | Znf_PHD-finger | 5.45e-06 | 79 | 105 | 6 | IPR019787 | |
| Domain | PHD | 1.09e-05 | 89 | 105 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.24e-05 | 91 | 105 | 6 | IPR001965 | |
| Domain | - | 1.50e-05 | 27 | 105 | 4 | 1.10.260.40 | |
| Domain | ZF_PHD_2 | 1.58e-05 | 95 | 105 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.68e-05 | 96 | 105 | 6 | PS01359 | |
| Domain | Lambda_DNA-bd_dom | 2.01e-05 | 29 | 105 | 4 | IPR010982 | |
| Domain | UBA | 2.31e-05 | 30 | 105 | 4 | SM00165 | |
| Domain | Mucin_dom | 3.13e-05 | 2 | 105 | 2 | IPR028199 | |
| Domain | Med13_N | 3.13e-05 | 2 | 105 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 3.13e-05 | 2 | 105 | 2 | IPR021643 | |
| Domain | Mediator_Med13 | 3.13e-05 | 2 | 105 | 2 | IPR009401 | |
| Domain | Ubiquilin-1/2 | 3.13e-05 | 2 | 105 | 2 | IPR028430 | |
| Domain | Epiglycanin_C | 3.13e-05 | 2 | 105 | 2 | PF14654 | |
| Domain | DUF3697 | 3.13e-05 | 2 | 105 | 2 | PF12478 | |
| Domain | Med13_C | 3.13e-05 | 2 | 105 | 2 | PF06333 | |
| Domain | DUF3697_Uba2 | 3.13e-05 | 2 | 105 | 2 | IPR022166 | |
| Domain | Zinc_finger_PHD-type_CS | 3.22e-05 | 65 | 105 | 5 | IPR019786 | |
| Domain | UBA | 4.84e-05 | 36 | 105 | 4 | PF00627 | |
| Domain | SEA | 6.01e-05 | 14 | 105 | 3 | SM00200 | |
| Domain | UBA | 1.08e-04 | 44 | 105 | 4 | IPR015940 | |
| Domain | UBA | 1.40e-04 | 47 | 105 | 4 | PS50030 | |
| Domain | Znf_FYVE_PHD | 1.82e-04 | 147 | 105 | 6 | IPR011011 | |
| Domain | EPHD | 2.46e-04 | 22 | 105 | 3 | PS51805 | |
| Domain | SEA | 2.82e-04 | 23 | 105 | 3 | PS50024 | |
| Domain | SEA_dom | 2.82e-04 | 23 | 105 | 3 | IPR000082 | |
| Domain | UBA-like | 4.62e-04 | 64 | 105 | 4 | IPR009060 | |
| Domain | Ubiquilin | 4.63e-04 | 6 | 105 | 2 | IPR015496 | |
| Domain | CUT | 6.45e-04 | 7 | 105 | 2 | PS51042 | |
| Domain | CUT | 6.45e-04 | 7 | 105 | 2 | PF02376 | |
| Domain | CUT_dom | 6.45e-04 | 7 | 105 | 2 | IPR003350 | |
| Domain | Cadherin_pro | 6.45e-04 | 7 | 105 | 2 | PF08758 | |
| Domain | CUT | 6.45e-04 | 7 | 105 | 2 | SM01109 | |
| Domain | Cadherin_pro_dom | 8.57e-04 | 8 | 105 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 8.57e-04 | 8 | 105 | 2 | SM01055 | |
| Domain | UBIQUITIN_1 | 1.17e-03 | 37 | 105 | 3 | PS00299 | |
| Domain | STI1 | 1.37e-03 | 10 | 105 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.37e-03 | 10 | 105 | 2 | IPR006636 | |
| Domain | UBQ | 1.81e-03 | 43 | 105 | 3 | SM00213 | |
| Domain | TIL | 1.99e-03 | 12 | 105 | 2 | PF01826 | |
| Domain | C8 | 1.99e-03 | 12 | 105 | 2 | PF08742 | |
| Domain | Homeobox | 2.08e-03 | 234 | 105 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.17e-03 | 236 | 105 | 6 | PS00027 | |
| Domain | HOX | 2.22e-03 | 237 | 105 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 2.31e-03 | 239 | 105 | 6 | PS50071 | |
| Domain | Homeobox_dom | 2.31e-03 | 239 | 105 | 6 | IPR001356 | |
| Domain | ubiquitin | 2.34e-03 | 47 | 105 | 3 | PF00240 | |
| Domain | Unchr_dom_Cys-rich | 2.35e-03 | 13 | 105 | 2 | IPR014853 | |
| Domain | C8 | 2.35e-03 | 13 | 105 | 2 | SM00832 | |
| Domain | TIL_dom | 2.73e-03 | 14 | 105 | 2 | IPR002919 | |
| Domain | - | 3.13e-03 | 15 | 105 | 2 | 3.30.70.960 | |
| Domain | UBIQUITIN_2 | 3.48e-03 | 54 | 105 | 3 | PS50053 | |
| Domain | POU | 3.57e-03 | 16 | 105 | 2 | SM00352 | |
| Domain | UDENN | 3.57e-03 | 16 | 105 | 2 | PS50946 | |
| Domain | DDENN | 3.57e-03 | 16 | 105 | 2 | PS50947 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | SM00216 | |
| Domain | POU_2 | 3.57e-03 | 16 | 105 | 2 | PS00465 | |
| Domain | POU_dom | 3.57e-03 | 16 | 105 | 2 | IPR000327 | |
| Domain | DENN | 3.57e-03 | 16 | 105 | 2 | SM00799 | |
| Domain | POU_3 | 3.57e-03 | 16 | 105 | 2 | PS51179 | |
| Domain | VWF_type-D | 3.57e-03 | 16 | 105 | 2 | IPR001846 | |
| Domain | dDENN | 3.57e-03 | 16 | 105 | 2 | SM00801 | |
| Domain | DENN | 3.57e-03 | 16 | 105 | 2 | PF02141 | |
| Domain | dDENN_dom | 3.57e-03 | 16 | 105 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.57e-03 | 16 | 105 | 2 | IPR005113 | |
| Domain | VWFD | 3.57e-03 | 16 | 105 | 2 | PS51233 | |
| Domain | dDENN | 3.57e-03 | 16 | 105 | 2 | PF03455 | |
| Domain | Pou | 3.57e-03 | 16 | 105 | 2 | PF00157 | |
| Domain | DENN | 3.57e-03 | 16 | 105 | 2 | PS50211 | |
| Domain | DENN_dom | 3.57e-03 | 16 | 105 | 2 | IPR001194 | |
| Domain | POU_1 | 3.57e-03 | 16 | 105 | 2 | PS00035 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | PF00094 | |
| Domain | - | 3.83e-03 | 449 | 105 | 8 | 3.30.40.10 | |
| Domain | POU | 4.03e-03 | 17 | 105 | 2 | IPR013847 | |
| Domain | Ubiquitin_dom | 4.26e-03 | 58 | 105 | 3 | IPR000626 | |
| Domain | Znf_RING/FYVE/PHD | 4.37e-03 | 459 | 105 | 8 | IPR013083 | |
| Domain | CTCK_1 | 4.52e-03 | 18 | 105 | 2 | PS01185 | |
| Domain | VWC_out | 5.03e-03 | 19 | 105 | 2 | SM00215 | |
| Domain | 6-PGluconate_DH_C-like | 5.03e-03 | 19 | 105 | 2 | IPR008927 | |
| Domain | - | 5.29e-03 | 283 | 105 | 6 | 1.10.10.60 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.17e-08 | 47 | 85 | 7 | MM14939 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.93e-08 | 16 | 85 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.14e-08 | 17 | 85 | 5 | M27412 | |
| Pathway | REACTOME_SUMOYLATION | DDX17 HIPK2 NUP214 NUP42 POM121C PIAS1 POM121 NCOA1 POM121B NUP153 | 6.78e-08 | 169 | 85 | 10 | MM14919 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.12e-07 | 39 | 85 | 6 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.18e-07 | 65 | 85 | 7 | MM15147 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.31e-07 | 40 | 85 | 6 | MM14945 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.33e-07 | 21 | 85 | 5 | MM15706 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.53e-07 | 41 | 85 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.77e-07 | 42 | 85 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.05e-07 | 43 | 85 | 6 | MM14609 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.19e-07 | 23 | 85 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.21e-07 | 26 | 85 | 5 | M27483 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 4.57e-07 | 49 | 85 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.16e-07 | 50 | 85 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 5.83e-07 | 51 | 85 | 6 | MM15151 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.95e-07 | 82 | 85 | 7 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.02e-07 | 84 | 85 | 7 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.20e-07 | 55 | 85 | 6 | MM14917 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.25e-06 | 32 | 85 | 5 | M29579 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.27e-06 | 58 | 85 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.27e-06 | 58 | 85 | 6 | MM14736 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.47e-06 | 33 | 85 | 5 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.72e-06 | 34 | 85 | 5 | M27041 | |
| Pathway | REACTOME_SUMOYLATION | 1.98e-06 | 189 | 85 | 9 | M27214 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.99e-06 | 35 | 85 | 5 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.30e-06 | 36 | 85 | 5 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.30e-06 | 36 | 85 | 5 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 2.65e-06 | 37 | 85 | 5 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 2.65e-06 | 37 | 85 | 5 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.21e-06 | 71 | 85 | 6 | M27394 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 4.47e-06 | 41 | 85 | 5 | M29574 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 4.95e-06 | 73 | 85 | 6 | MM14948 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.69e-06 | 43 | 85 | 5 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 6.39e-06 | 44 | 85 | 5 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.77e-06 | 77 | 85 | 6 | M27226 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.99e-06 | 46 | 85 | 5 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.90e-06 | 47 | 85 | 5 | M27395 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.20e-05 | 85 | 85 | 6 | M1870 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.29e-05 | 86 | 85 | 6 | MM15413 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.62e-05 | 53 | 85 | 5 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.77e-05 | 54 | 85 | 5 | M29594 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.89e-05 | 92 | 85 | 6 | MM14951 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 2.74e-05 | 59 | 85 | 5 | M27606 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.98e-05 | 60 | 85 | 5 | MM15636 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SP1 INTS12 HIPK1 HIPK2 POU2F1 NUP214 NUP42 MED1 POM121C AKAP8L POM121 KMT2A SMARCE1 ZFHX3 POM121B NUP153 AFF4 RNF111 | 3.04e-05 | 1022 | 85 | 18 | MM15436 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.50e-05 | 62 | 85 | 5 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.47e-05 | 68 | 85 | 5 | M27303 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 6.37e-05 | 114 | 85 | 6 | MM15361 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 7.73e-05 | 118 | 85 | 6 | M27316 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 8.22e-05 | 74 | 85 | 5 | M48006 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 9.53e-05 | 40 | 85 | 4 | MM15000 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.11e-04 | 126 | 85 | 6 | M45009 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.34e-04 | 82 | 85 | 5 | M27250 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.39e-04 | 44 | 85 | 4 | M27295 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.50e-04 | 84 | 85 | 5 | M1008 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.50e-04 | 84 | 85 | 5 | M725 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.98e-04 | 140 | 85 | 6 | M27484 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.25e-04 | 99 | 85 | 5 | M27474 | |
| Pathway | WP_MIR222_IN_EXERCISEINDUCED_CARDIAC_GROWTH | 3.55e-04 | 5 | 85 | 2 | MM15988 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.56e-04 | 101 | 85 | 5 | M27253 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.91e-04 | 24 | 85 | 3 | M13404 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 3.91e-04 | 24 | 85 | 3 | MM15658 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.45e-04 | 106 | 85 | 5 | M27458 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | MUC21 DDX17 MUC19 HIPK2 MUC16 MUC5B NUP214 NUP42 POM121C PIAS1 POM121 MUC17 ATXN7 SEC23IP NCOA1 TAB1 POM121B CDH2 NUP153 | 5.03e-04 | 1389 | 85 | 19 | MM15307 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.06e-04 | 109 | 85 | 5 | MM15164 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.27e-04 | 110 | 85 | 5 | M48259 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.50e-04 | 111 | 85 | 5 | M27416 | |
| Pathway | REACTOME_TRNA_PROCESSING | 5.50e-04 | 111 | 85 | 5 | M27684 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 6.72e-04 | 116 | 85 | 5 | M29806 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.83e-04 | 8 | 85 | 2 | M22058 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | MUC21 DDX17 HIPK2 MUC16 MUC5B NUP214 NUP42 POM121C PIAS1 POM121 MUC17 ATXN7 SEC23IP ASPH NCOA1 TAB1 MUC3A CDH2 NUP153 | 1.05e-03 | 1475 | 85 | 19 | M19806 |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 1.16e-03 | 131 | 85 | 5 | M5283 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.20e-03 | 35 | 85 | 3 | M47969 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.24e-03 | 271 | 85 | 7 | MM15406 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.40e-03 | 277 | 85 | 7 | MM15414 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.42e-03 | 37 | 85 | 3 | M27797 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.44e-03 | 204 | 85 | 6 | M45011 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.46e-03 | 138 | 85 | 5 | M29805 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.51e-03 | 139 | 85 | 5 | M715 | |
| Pathway | PID_CMYB_PATHWAY | 1.65e-03 | 84 | 85 | 4 | M195 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.66e-03 | 142 | 85 | 5 | M27660 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.71e-03 | 143 | 85 | 5 | M27275 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.78e-03 | 40 | 85 | 3 | MM15060 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.91e-03 | 11 | 85 | 2 | M22033 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.05e-03 | 42 | 85 | 3 | M27172 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 2.05e-03 | 149 | 85 | 5 | M4076 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.18e-03 | 151 | 85 | 5 | M550 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.21e-03 | 91 | 85 | 4 | M39700 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 2.58e-03 | 157 | 85 | 5 | M4669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 2.68e-03 | 13 | 85 | 2 | M47440 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 2.89e-03 | 98 | 85 | 4 | M48247 | |
| Pathway | REACTOME_HCMV_INFECTION | 2.95e-03 | 162 | 85 | 5 | M29804 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.01e-03 | 48 | 85 | 3 | MM15069 | |
| Pathway | REACTOME_PHYSIOLOGICAL_FACTORS | 3.12e-03 | 14 | 85 | 2 | M27459 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 3.59e-03 | 15 | 85 | 2 | M603 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 3.59e-03 | 15 | 85 | 2 | M119 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 3.78e-03 | 52 | 85 | 3 | M2404 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.99e-03 | 250 | 85 | 6 | M27554 | |
| Pathway | PID_AR_TF_PATHWAY | 3.99e-03 | 53 | 85 | 3 | M151 | |
| Pubmed | SP1 EYA4 UBAP2 INTS12 RSL1D1 UBR4 ZMYND8 HIPK2 POU2F1 NUP214 SIX4 MLLT10 HRNR POM121C RFX1 PIAS1 AKAP8L ARID1B UBE2O ZNF608 MAGED2 UBAP2L ATXN7 NCOA1 LRP6 KMT2A SMARCE1 MLLT6 ZFHX3 LSM14A SRRM2 | 1.28e-17 | 1429 | 112 | 31 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 SP1 UBAP2 UBQLN2 UBQLN1 TRO UBR4 ZMYND8 NUP214 MLLT10 HRNR POM121C PIAS1 TULP3 POM121 NFE2L1 MLLT6 CAMSAP1 NUP153 | 1.86e-16 | 430 | 112 | 19 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | EYA4 POU2F1 NUP214 SIX4 HRNR POM121C PIAS1 AKAP8L ARID1B ZNF608 NCOA1 KMT2A SMARCE1 ZFHX3 CDH2 MED12 | 3.26e-14 | 351 | 112 | 16 | 38297188 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 RSL1D1 ZMYND8 FNBP4 KDM3B POU2F1 NUP214 MED1 RFX1 AKAP8L FBXO38 MAGED2 UBAP2L ATXN7 EIF4B ASPH KMT2A SRRM2 BAG6 MED13 NUP153 | 6.47e-14 | 774 | 112 | 21 | 15302935 |
| Pubmed | DDX17 UBQLN1 INTS12 PCLAF RSL1D1 ZMYND8 KDM3B POU2F1 MED13L MED1 RFX1 PIAS1 ARID1B EIF4B NCOA1 KMT2A SMARCE1 MLLT6 LSM14A SRRM2 BAG6 MED12 NUP153 | 8.51e-13 | 1103 | 112 | 23 | 34189442 | |
| Pubmed | INTS12 ZMYND8 KDM3B MED13L MED1 ARID1B ZNF608 NCOA1 KMT2A SMARCE1 MED12 MED13 AFF4 | 4.35e-12 | 268 | 112 | 13 | 33640491 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | UBAP2 RSL1D1 FNBP4 NUP214 MED1 POM121C AKAP8L SMG8 ARID1B POM121 SBF1 MAGED2 UBAP2L CAMSAP1 NUP153 | 1.38e-11 | 440 | 112 | 15 | 34244565 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | DDX17 UBAP2 RSL1D1 PPP1R12A ZMYND8 RSF1 KDM3B NUP214 MED1 POM121C UBE2O UBAP2L EIF4B SEC23IP KMT2A SMARCE1 LSM14A CAMSAP1 NUP153 AFF4 | 1.98e-11 | 934 | 112 | 20 | 33916271 |
| Pubmed | SP1 UBR4 RSF1 KDM3B MUC16 NBEA MED1 POM121C RFX1 PIAS1 PHLDB1 ARID1B ATXN7 SEC23IP NCOA1 RAB11FIP5 SMARCE1 | 2.61e-11 | 638 | 112 | 17 | 31182584 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRG1 RSL1D1 PPP1R12A ZMYND8 OBSCN FNBP4 NBEA NUP214 AKAP8L PHLDB1 EIF4B CD24 KMT2A BAG6 MED12 | 7.58e-11 | 497 | 112 | 15 | 36774506 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RSL1D1 UBR4 ZMYND8 KDM3B MED1 POM121C RFX1 ARID1B KMT2A SRRM2 MED12 NUP153 AFF4 | 8.76e-11 | 341 | 112 | 13 | 32971831 |
| Pubmed | ONECUT2 SP1 INTS12 ZMYND8 KDM3B POU2F1 NUP42 SIX4 MLLT10 RFX1 ONECUT1 PIAS1 NFE2L1 SLTM NCOA1 SMARCE1 MLLT6 ZFHX3 | 1.19e-10 | 808 | 112 | 18 | 20412781 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DDX17 UBAP2 RSL1D1 ZMYND8 RSF1 FNBP4 NUP214 MED1 RFX1 ARID1B UBAP2L EIF4B SLTM KMT2A SMARCE1 MLLT6 SRRM2 NUP153 AFF4 | 2.26e-10 | 954 | 112 | 19 | 36373674 |
| Pubmed | UBQLN2 UBQLN1 HIPK1 UBR4 ZMYND8 FNBP4 KDM3B CILK1 RFX1 PIAS1 ARID1B SMARCE1 CAMSAP1 BAG6 RNF111 | 8.22e-10 | 591 | 112 | 15 | 15231748 | |
| Pubmed | 9.26e-10 | 15 | 112 | 5 | 14697343 | ||
| Pubmed | CDSN DDX17 ROR2 UBR4 KDM3B MED13L ZNF608 SMARCE1 TAB1 MED12 MED13 | 1.43e-09 | 272 | 112 | 11 | 31010829 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.47e-09 | 38 | 112 | 6 | 12791264 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.62e-09 | 18 | 112 | 5 | 18834073 | |
| Pubmed | RSL1D1 PPP1R12A RSF1 MED13L MED1 DENND4C UBE2O ZNF608 UBAP2L SLTM KMT2A CAMSAP1 BAG6 MED12 MED13 | 2.69e-09 | 645 | 112 | 15 | 25281560 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | DDX17 ZMYND8 KDM3B HIPK2 PIAS1 ARID1B NCOA1 SMARCE1 ZFHX3 MED12 | 2.70e-09 | 220 | 112 | 10 | 35785414 |
| Pubmed | UBAP2 PPP1R12A FNBP4 KDM3B MED1 RFX1 ARID1B UBE2O UBAP2L SEC23IP KMT2A SMARCE1 TAB1 MED12 | 2.95e-09 | 549 | 112 | 14 | 38280479 | |
| Pubmed | DOCK3 UBQLN2 UBQLN1 RSL1D1 HIPK1 UBR4 ZMYND8 NBEA NUP42 MED13L PIAS1 AKAP8L FRY UBE2O SEC23IP RNF10 SMARCE1 MED13 AFF4 RNF111 | 5.00e-09 | 1285 | 112 | 20 | 35914814 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L DDX17 BCAS3 KDM3B AKAP8L DENND4C PHLDB1 MAGED2 UBAP2L EIF4B SEC23IP RNF10 RAB11FIP5 SMARCE1 LSM14A TAB1 MED12 EVI5L | 6.17e-09 | 1038 | 112 | 18 | 26673895 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.80e-09 | 123 | 112 | 8 | 26912792 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RSL1D1 HIPK1 CILK1 MED13L MED1 RBM23 FRY MAGED2 UBAP2L SRRM2 BAG6 MED12 MED13 AFF4 EVI5L | 7.30e-09 | 695 | 112 | 15 | 23602568 |
| Pubmed | UBQLN1 INTS12 PPP1R12A ZMYND8 SIX4 MED1 PIAS1 RBM23 AKAP8L SBF1 ATXN7 EIF4B ASPH KMT2A FAM83D SMARCE1 ZFHX3 LSM14A MED12 MED13 AFF4 | 1.20e-08 | 1497 | 112 | 21 | 31527615 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 INTS12 BCAS3 PPP1R12A ROR2 KDM3B DENND4C PHLDB1 SBF1 EIF4B RNF10 RAB11FIP5 KMT2A TAB1 CAMSAP1 SRRM2 | 1.80e-08 | 861 | 112 | 16 | 36931259 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CDSN KDM3B MED1 PIAS1 ZNF608 MAGED2 UBAP2L ATXN7 EIF4B SLTM RAB11FIP5 TAB1 | 2.26e-08 | 444 | 112 | 12 | 34795231 |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 3.25e-08 | 3 | 112 | 3 | 30802453 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 35507432 | ||
| Pubmed | 7.12e-08 | 13 | 112 | 4 | 27570068 | ||
| Pubmed | SP1 ZMYND8 POU2F1 SIX4 MLLT10 ONECUT1 PIAS1 NFE2L1 RNF10 NCOA1 KMT2A SMARCE1 ZFHX3 RNF111 | 7.20e-08 | 709 | 112 | 14 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | INTS12 RSF1 KDM3B POU2F1 MED1 RFX1 PIAS1 FBXO38 UBE2O KMT2A SMARCE1 MLLT6 AFF4 | 8.77e-08 | 608 | 112 | 13 | 36089195 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 BCAS3 UBR4 OBSCN KDM3B NUP214 MLLT10 MED13L POM121C GAS2L1 PHLDB1 SBF1 MLLT6 CAMSAP1 MED12 MED13 EVI5L | 9.54e-08 | 1105 | 112 | 17 | 35748872 |
| Pubmed | UBR4 ZMYND8 NUP214 RFX1 AKAP8L DENND4C ZNF608 SEC23IP ZFHX3 CAMSAP1 MED12 | 1.17e-07 | 418 | 112 | 11 | 34709266 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EYA4 ROR2 MUC16 HRNR SBF1 MAGED2 UBAP2L EIF4B LSM14A TAB1 SRRM2 | 1.23e-07 | 420 | 112 | 11 | 28065597 |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.30e-07 | 4 | 112 | 3 | 17900573 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ONECUT2 SP1 EYA4 DDX17 INTS12 RSL1D1 ZMYND8 FNBP4 NUP214 SIX4 MED1 POM121C ASPH SLTM KMT2A SMARCE1 SRRM2 NUP153 | 1.72e-07 | 1294 | 112 | 18 | 30804502 |
| Pubmed | ROR2 NUP42 POM121C UBE2O POM121 SEC23IP RAB11FIP5 CAMSAP1 NUP153 | 1.97e-07 | 263 | 112 | 9 | 34702444 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POU6F2 BCAS3 PPP1R12A ROR2 OBSCN FNBP4 HIPK2 CILK1 TULP3 PHLDB1 ZNF608 UBAP2L ATXN7 ASPH SLC9A7 ZFHX3 LSM14A AFF4 EVI5L | 2.82e-07 | 1489 | 112 | 19 | 28611215 |
| Pubmed | 3.01e-07 | 83 | 112 | 6 | 28794006 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 3.80e-07 | 19 | 112 | 4 | 16799563 | |
| Pubmed | DDX17 ROR2 NUP214 DENND4C MAGED2 UBAP2L EIF4B SEC23IP RAB11FIP5 LRP6 CAMSAP1 MED12 NUP153 | 4.95e-07 | 708 | 112 | 13 | 39231216 | |
| Pubmed | UBAP2 PPP1R12A DLGAP4 UBR4 NBEA FRY UBE2O SBF1 MAGED2 UBAP2L SEC23IP CAMSAP1 CDH2 NUP153 AFF4 | 4.99e-07 | 963 | 112 | 15 | 28671696 | |
| Pubmed | DDX17 UBAP2 RSL1D1 PPP1R12A ZMYND8 FNBP4 AKAP8L ASPH SLTM KMT2A SMARCE1 LSM14A SRRM2 NUP153 | 6.14e-07 | 847 | 112 | 14 | 35850772 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 19110483 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EYA4 INTS12 BCAS3 HIPK1 TRO PPP1R12A UBR4 ZMYND8 POU2F1 SIX4 HRNR RFX1 SMARCE1 CAMSAP1 | 7.06e-07 | 857 | 112 | 14 | 25609649 |
| Pubmed | 7.13e-07 | 22 | 112 | 4 | 11867769 | ||
| Pubmed | SP1 EYA4 DDX17 RSL1D1 RSF1 MED1 DENND4C UBAP2L SRRM2 BAG6 NUP153 | 7.33e-07 | 503 | 112 | 11 | 16964243 | |
| Pubmed | DDX17 INTS12 RSL1D1 TRO PPP1R12A UBR4 RSF1 KRT79 AKAP8L KRT75 ZNF608 MAGED2 ATXN7 EIF4B SEC23IP KMT2A LSM14A MED13 | 8.28e-07 | 1442 | 112 | 18 | 35575683 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 8.61e-07 | 23 | 112 | 4 | 10235267 | |
| Pubmed | 9.40e-07 | 233 | 112 | 8 | 37704626 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.05e-06 | 163 | 112 | 7 | 22113938 | |
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 12093747 | ||
| Pubmed | UBAP2 PCLAF FNBP4 KDM3B ARID1B UBE2O SBF1 ZNF608 RNF10 RAB11FIP5 MED13 | 1.20e-06 | 529 | 112 | 11 | 14621295 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 1.35e-06 | 107 | 112 | 6 | 20508642 | |
| Pubmed | RSL1D1 UBR4 RSF1 NUP214 UBE2O SBF1 UBAP2L SLTM KMT2A SRRM2 MED12 NUP153 | 1.39e-06 | 653 | 112 | 12 | 22586326 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | UBAP2 NUP214 MED13L AKAP8L ARID1B UBE2O RAB11FIP5 SRRM2 CDH4 NUP153 | 1.41e-06 | 431 | 112 | 10 | 33660365 |
| Pubmed | 1.44e-06 | 26 | 112 | 4 | 12228227 | ||
| Pubmed | DOCK3 PPP1R12A NBEA NUP214 NUP42 AKAP8L MAGED2 UBAP2L KMT2A SMARCE1 LSM14A TAB1 NUP153 EVI5L | 1.54e-06 | 916 | 112 | 14 | 32203420 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ONECUT2 UBAP2 PCLAF RSF1 RFX1 ONECUT1 PIAS1 ARID1B ZNF608 ASPH RAB11FIP5 SRRM2 CDH2 BAG6 MED12 RNF111 | 1.60e-06 | 1203 | 112 | 16 | 29180619 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ONECUT2 CDSN DDX17 ZMYND8 FNBP4 HRNR MED1 AKAP8L ARID1B SBF1 SLTM SMARCE1 SRRM2 MED12 AFF4 | 2.11e-06 | 1082 | 112 | 15 | 38697112 |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 2.27e-06 | 353 | 112 | 9 | 27545878 | |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 2.62e-06 | 30 | 112 | 4 | 24315095 | |
| Pubmed | 2.62e-06 | 30 | 112 | 4 | 27016207 | ||
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 2.69e-06 | 9 | 112 | 3 | 8710870 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.72e-06 | 361 | 112 | 9 | 26167880 | |
| Pubmed | 3.00e-06 | 31 | 112 | 4 | 23322298 | ||
| Pubmed | PPP1R12A ZMYND8 SIX4 MED1 RFX1 ARID1B RAB11FIP5 CAMSAP1 SRRM2 MED12 | 3.18e-06 | 472 | 112 | 10 | 38943005 | |
| Pubmed | Streamlined analysis schema for high-throughput identification of endogenous protein complexes. | 3.48e-06 | 71 | 112 | 5 | 20133760 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | CDSN DDX17 UBAP2 UBQLN2 PPP1R12A UBE2O MAGED2 EIF4B SRRM2 BAG6 | 3.48e-06 | 477 | 112 | 10 | 31300519 |
| Pubmed | A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. | 3.84e-06 | 10 | 112 | 3 | 12218053 | |
| Pubmed | 3.84e-06 | 10 | 112 | 3 | 12738788 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 3.84e-06 | 10 | 112 | 3 | 23746844 | |
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 3.99e-06 | 73 | 112 | 5 | 21729782 | |
| Pubmed | SP1 HIPK1 HIPK2 NUP214 NUP42 POM121C PIAS1 POM121 NUP153 RNF111 | 4.11e-06 | 486 | 112 | 10 | 20936779 | |
| Pubmed | DDX17 RSL1D1 CILK1 HRNR MED1 KRT79 ARID1B UBE2O KRT75 MAGED2 UBAP2L SMARCE1 LSM14A BAG6 NUP153 | 4.56e-06 | 1153 | 112 | 15 | 29845934 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.00e-06 | 134 | 112 | 6 | 25452129 | |
| Pubmed | 5.54e-06 | 78 | 112 | 5 | 25720964 | ||
| Pubmed | 6.11e-06 | 399 | 112 | 9 | 35987950 | ||
| Pubmed | 6.20e-06 | 37 | 112 | 4 | 34147029 | ||
| Pubmed | 6.91e-06 | 38 | 112 | 4 | 28680062 | ||
| Pubmed | 7.00e-06 | 12 | 112 | 3 | 23563140 | ||
| Pubmed | PAQR9 Modulates BAG6-mediated protein quality control of mislocalized membrane proteins. | 7.00e-06 | 12 | 112 | 3 | 31904842 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CDSN DDX17 RSL1D1 UBR4 RSF1 NUP214 AKAP8L SMG8 PHLDB1 SBF1 MAGED2 ASPH SLTM SRRM2 BAG6 MED12 | 7.13e-06 | 1353 | 112 | 16 | 29467282 |
| Pubmed | 7.16e-06 | 407 | 112 | 9 | 12693553 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DDX17 UBR4 HRNR PIAS1 FRY SBF1 MAGED2 RAB11FIP5 KMT2A SMARCE1 SRRM2 | 7.25e-06 | 639 | 112 | 11 | 23443559 |
| Pubmed | EYA4 NBEA SIX4 AKAP8L TULP3 FBXO38 ARID1B SBF1 SLTM RAB11FIP5 LRP6 TAB1 SRRM2 NUP153 | 7.31e-06 | 1049 | 112 | 14 | 27880917 | |
| Pubmed | 7.87e-06 | 145 | 112 | 6 | 28846114 | ||
| Pubmed | A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. | 9.08e-06 | 13 | 112 | 3 | 14657022 | |
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 9.08e-06 | 13 | 112 | 3 | 20098423 | |
| Pubmed | 9.08e-06 | 13 | 112 | 3 | 22102297 | ||
| Pubmed | DDX17 PCLAF RSL1D1 NUP214 POM121C AKAP8L MAGED2 UBAP2L LSM14A SRRM2 NUP153 | 9.14e-06 | 655 | 112 | 11 | 35819319 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8668525 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8247017 | ||
| Pubmed | Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. | 1.03e-05 | 2 | 112 | 2 | 38127465 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29247619 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 35063704 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12127405 | ||
| Pubmed | Dose-dependent regulation of horizontal cell fate by Onecut family of transcription factors. | 1.03e-05 | 2 | 112 | 2 | 32790713 | |
| Interaction | NUP43 interactions | DDX17 RSL1D1 PPP1R12A ZMYND8 RSF1 MUC19 NUP214 NUP42 POM121C ARID1B POM121 ZNF608 KMT2A SMARCE1 MLLT6 ZFHX3 FAM199X SRRM2 MED12 NUP153 | 1.15e-10 | 625 | 108 | 20 | int:NUP43 |
| Interaction | AR interactions | SP1 DDX17 INTS12 ZMYND8 KDM3B HIPK2 POU2F1 HRNR MED13L MED1 PIAS1 ARID1B ZNF608 UBAP2L NCOA1 KMT2A FAM83D SMARCE1 ZFHX3 BAG6 MED12 MED13 AFF4 | 2.16e-09 | 992 | 108 | 23 | int:AR |
| Interaction | SIRT6 interactions | UBAP2 RSL1D1 FNBP4 NUP214 MED1 POM121C PIAS1 AKAP8L SMG8 ARID1B POM121 SBF1 MAGED2 UBAP2L CAMSAP1 BAG6 MED12 NUP153 | 6.16e-09 | 628 | 108 | 18 | int:SIRT6 |
| Interaction | NR3C1 interactions | DOCK3 SP1 UBR4 RSF1 KDM3B MUC16 POU2F1 NBEA NUP214 MED1 POM121C RFX1 ONECUT1 PIAS1 PHLDB1 ARID1B ATXN7 SEC23IP NCOA1 RAB11FIP5 SMARCE1 NUP153 | 8.24e-09 | 974 | 108 | 22 | int:NR3C1 |
| Interaction | MAGED1 interactions | EYA4 UBQLN2 ROR2 RFX1 PIAS1 RBM23 AKAP8L UBE2O POM121 MAGED2 TAB1 BAG6 | 6.18e-08 | 295 | 108 | 12 | int:MAGED1 |
| Interaction | USP7 interactions | DOCK3 SP1 EYA4 SNPH DDX17 UBAP2 PCLAF RSL1D1 TRO PPP1R12A ZMYND8 HRNR TULP3 EZHIP FBXO38 GAS2L1 UBE2O MAGED2 NFE2L1 EIF4B CAMSAP1 SRRM2 BAG6 AFF4 | 8.91e-08 | 1313 | 108 | 24 | int:USP7 |
| Interaction | PML interactions | SP1 CDSN RSL1D1 HIPK1 KDM3B HIPK2 MED1 PIAS1 TULP3 EZHIP ZNF608 MAGED2 UBAP2L ATXN7 EIF4B SLTM RAB11FIP5 KMT2A TAB1 RNF111 | 1.03e-07 | 933 | 108 | 20 | int:PML |
| Interaction | MEN1 interactions | DDX17 UBAP2 RSL1D1 UBR4 ZMYND8 FNBP4 KDM3B MED1 POM121C RFX1 AKAP8L ARID1B ZNF608 ASPH SLTM KMT2A SMARCE1 SRRM2 MED12 NUP153 AFF4 | 1.07e-07 | 1029 | 108 | 21 | int:MEN1 |
| Interaction | TLE3 interactions | DDX17 SIX4 MLLT10 PIAS1 AKAP8L ARID1B POM121 ZNF608 NCOA1 KMT2A MLLT6 ZFHX3 SRRM2 | 1.12e-07 | 376 | 108 | 13 | int:TLE3 |
| Interaction | CRX interactions | SP1 ROR2 POU2F1 PIAS1 ARID1B ZNF608 ATXN7 NCOA1 MLLT6 ZFHX3 MED12 | 1.21e-07 | 254 | 108 | 11 | int:CRX |
| Interaction | CEBPA interactions | DDX17 UBQLN1 INTS12 PCLAF RSL1D1 ZMYND8 KDM3B POU2F1 MED13L MED1 RFX1 PIAS1 ARID1B EIF4B NCOA1 KMT2A SMARCE1 MLLT6 LSM14A SRRM2 BAG6 MED12 NUP153 | 1.45e-07 | 1245 | 108 | 23 | int:CEBPA |
| Interaction | FBXO22 interactions | NRG1 RSL1D1 PPP1R12A ZMYND8 OBSCN FNBP4 NBEA NUP214 AKAP8L PHLDB1 EIF4B CD24 KMT2A BAG6 MED12 | 1.92e-07 | 540 | 108 | 15 | int:FBXO22 |
| Interaction | NAA40 interactions | DDX17 UBAP2 RSL1D1 PPP1R12A ZMYND8 RSF1 KDM3B NUP214 MED1 POM121C UBE2O UBAP2L EIF4B SEC23IP KMT2A SMARCE1 LSM14A CAMSAP1 NUP153 AFF4 | 2.19e-07 | 978 | 108 | 20 | int:NAA40 |
| Interaction | YAP1 interactions | DDX17 UBAP2 UBQLN2 UBQLN1 PPP1R12A FNBP4 KDM3B HRNR MED1 KRT79 RFX1 ARID1B UBE2O KRT75 UBAP2L EIF4B KMT2A SMARCE1 TAB1 SRRM2 MED12 | 3.02e-07 | 1095 | 108 | 21 | int:YAP1 |
| Interaction | MED15 interactions | 5.25e-07 | 131 | 108 | 8 | int:MED15 | |
| Interaction | PRPF40A interactions | DDX17 UBQLN2 UBQLN1 HIPK1 PPP1R12A UBR4 FNBP4 PIAS1 AKAP8L SMARCE1 ZFHX3 SRRM2 BAG6 | 7.84e-07 | 446 | 108 | 13 | int:PRPF40A |
| Interaction | HNF1B interactions | 8.53e-07 | 190 | 108 | 9 | int:HNF1B | |
| Interaction | SOX15 interactions | 9.19e-07 | 141 | 108 | 8 | int:SOX15 | |
| Interaction | DOT1L interactions | DDX17 UBAP2 RSL1D1 PPP1R12A ZMYND8 FNBP4 MLLT10 AKAP8L ASPH SLTM KMT2A SMARCE1 MLLT6 LSM14A SRRM2 BAG6 NUP153 | 1.34e-06 | 807 | 108 | 17 | int:DOT1L |
| Interaction | SMC5 interactions | DDX17 UBAP2 RSL1D1 ZMYND8 RSF1 FNBP4 NUP214 MED1 RFX1 ARID1B UBAP2L EIF4B SLTM KMT2A SMARCE1 MLLT6 SRRM2 NUP153 AFF4 | 1.39e-06 | 1000 | 108 | 19 | int:SMC5 |
| Interaction | FEV interactions | 1.48e-06 | 203 | 108 | 9 | int:FEV | |
| Interaction | RNF31 interactions | DDX17 UBAP2 INTS12 NUP214 HRNR AKAP8L UBE2O ATXN7 EIF4B FAM83D TAB1 SRRM2 | 1.72e-06 | 403 | 108 | 12 | int:RNF31 |
| Interaction | FHL3 interactions | 2.35e-06 | 276 | 108 | 10 | int:FHL3 | |
| Interaction | CTAG1B interactions | 2.53e-06 | 113 | 108 | 7 | int:CTAG1B | |
| Interaction | CSTF2 interactions | 2.99e-06 | 165 | 108 | 8 | int:CSTF2 | |
| Interaction | RNF43 interactions | DDX17 ROR2 OBSCN NUP42 POM121C AKAP8L UBE2O POM121 SEC23IP RAB11FIP5 CAMSAP1 NUP153 | 3.12e-06 | 427 | 108 | 12 | int:RNF43 |
| Interaction | ERG interactions | 3.21e-06 | 223 | 108 | 9 | int:ERG | |
| Interaction | SRGN interactions | 3.54e-06 | 20 | 108 | 4 | int:SRGN | |
| Interaction | CREBBP interactions | SP1 EYA4 DDX17 HIPK1 KDM3B HIPK2 ONECUT1 PIAS1 FBXO38 ARID1B NCOA1 KMT2A CDH2 RNF111 | 3.86e-06 | 599 | 108 | 14 | int:CREBBP |
| Interaction | EGR2 interactions | 3.90e-06 | 171 | 108 | 8 | int:EGR2 | |
| Interaction | MLLT1 interactions | 4.45e-06 | 123 | 108 | 7 | int:MLLT1 | |
| Interaction | SMIM19 interactions | 5.16e-06 | 7 | 108 | 3 | int:SMIM19 | |
| Interaction | SOX2 interactions | DDX17 RSL1D1 PPP1R12A UBR4 ZMYND8 POU2F1 NUP214 SIX4 MED13L MED1 RFX1 PIAS1 AKAP8L ARID1B ZNF608 MAGED2 ASPH SLTM KMT2A SMARCE1 ZFHX3 LSM14A | 5.39e-06 | 1422 | 108 | 22 | int:SOX2 |
| Interaction | PGR interactions | 5.96e-06 | 84 | 108 | 6 | int:PGR | |
| Interaction | SMAD1 interactions | 6.44e-06 | 243 | 108 | 9 | int:SMAD1 | |
| Interaction | WFDC12 interactions | 8.22e-06 | 8 | 108 | 3 | int:WFDC12 | |
| Interaction | SMG7 interactions | SECISBP2L SIX4 MLLT10 ARID1B UBE2O ZNF608 UBAP2L NCOA1 MLLT6 LSM14A | 8.44e-06 | 319 | 108 | 10 | int:SMG7 |
| Interaction | MDK interactions | 9.49e-06 | 91 | 108 | 6 | int:MDK | |
| Interaction | MDM2 interactions | SP1 DDX17 RSL1D1 HIPK1 HIPK2 HRNR MED1 PIAS1 UBE2O MAGED2 RNF10 SMARCE1 TAB1 BAG6 | 1.12e-05 | 658 | 108 | 14 | int:MDM2 |
| Interaction | GATA2 interactions | 1.19e-05 | 199 | 108 | 8 | int:GATA2 | |
| Interaction | H3C3 interactions | INTS12 RSF1 KDM3B POU2F1 MED1 PIAS1 FBXO38 UBE2O KMT2A SMARCE1 MLLT6 AFF4 | 1.39e-05 | 495 | 108 | 12 | int:H3C3 |
| Interaction | NUP50 interactions | UBAP2 FNBP4 KDM3B NUP214 MED1 RFX1 POM121 KMT2A SRRM2 NUP153 | 1.50e-05 | 341 | 108 | 10 | int:NUP50 |
| Interaction | RNF4 interactions | ONECUT2 SP1 UBAP2 UBQLN2 UBQLN1 PCLAF RSF1 RFX1 ONECUT1 PIAS1 ARID1B ZNF608 ATXN7 ASPH NCOA1 RAB11FIP5 SRRM2 CDH2 BAG6 MED12 RNF111 | 1.67e-05 | 1412 | 108 | 21 | int:RNF4 |
| Interaction | SUMO2 interactions | SP1 DDX17 UBR4 ZMYND8 HIPK2 NUP214 PIAS1 FBXO38 UBAP2L ATXN7 SRRM2 NUP153 RNF111 | 1.67e-05 | 591 | 108 | 13 | int:SUMO2 |
| Interaction | HNF4A interactions | 1.73e-05 | 275 | 108 | 9 | int:HNF4A | |
| Interaction | YWHAH interactions | UBAP2 INTS12 BCAS3 PPP1R12A ROR2 KDM3B MED1 DENND4C PHLDB1 SBF1 EIF4B RNF10 NCOA1 RAB11FIP5 KMT2A TAB1 CAMSAP1 SRRM2 | 2.16e-05 | 1102 | 108 | 18 | int:YWHAH |
| Interaction | PAQR9 interactions | 2.39e-05 | 11 | 108 | 3 | int:PAQR9 | |
| Interaction | TLX3 interactions | 2.71e-05 | 291 | 108 | 9 | int:TLX3 | |
| Interaction | NXF1 interactions | SP1 UBQLN1 RSL1D1 DLGAP4 ROR2 UBR4 OBSCN FNBP4 NUP214 NUP42 POM121C PIAS1 FBXO38 UBE2O POM121 UBAP2L RNF10 SMARCE1 TAB1 NUP153 | 2.75e-05 | 1345 | 108 | 20 | int:NXF1 |
| Interaction | HEXIM1 interactions | DDX17 HIPK2 CILK1 HRNR MED1 KRT79 TULP3 ARID1B UBE2O KRT75 MAGED2 UBAP2L SMARCE1 LSM14A BAG6 AFF4 | 2.81e-05 | 913 | 108 | 16 | int:HEXIM1 |
| Interaction | TP53BP1 interactions | POU6F2 UBAP2 RSF1 MED13L MED1 RFX1 AKAP8L EZHIP ARID1B SMARCE1 MED12 MED13 | 2.88e-05 | 533 | 108 | 12 | int:TP53BP1 |
| Interaction | MED4 interactions | RSL1D1 MED13L MED1 DENND4C UBE2O UBAP2L SMARCE1 CAMSAP1 BAG6 MED12 MED13 | 3.00e-05 | 450 | 108 | 11 | int:MED4 |
| Interaction | TOP3B interactions | DOCK3 UBAP2 BCAS3 UBR4 OBSCN KDM3B NUP214 MLLT10 MED13L POM121C AKAP8L GAS2L1 PHLDB1 SBF1 UBAP2L MLLT6 LSM14A CAMSAP1 MED12 MED13 EVI5L | 3.03e-05 | 1470 | 108 | 21 | int:TOP3B |
| Interaction | NFIX interactions | 3.07e-05 | 227 | 108 | 8 | int:NFIX | |
| Interaction | FDCSP interactions | 3.18e-05 | 12 | 108 | 3 | int:FDCSP | |
| Interaction | ZG16 interactions | 3.18e-05 | 12 | 108 | 3 | int:ZG16 | |
| Interaction | NR1H2 interactions | 3.21e-05 | 68 | 108 | 5 | int:NR1H2 | |
| Interaction | TSG101 interactions | 3.71e-05 | 303 | 108 | 9 | int:TSG101 | |
| Interaction | SP7 interactions | 3.81e-05 | 304 | 108 | 9 | int:SP7 | |
| Interaction | TGM7 interactions | 4.03e-05 | 36 | 108 | 4 | int:TGM7 | |
| Interaction | PLAAT2 interactions | 4.12e-05 | 13 | 108 | 3 | int:PLAAT2 | |
| Interaction | SOD3 interactions | 4.12e-05 | 13 | 108 | 3 | int:SOD3 | |
| Interaction | SUMO3 interactions | 6.02e-05 | 126 | 108 | 6 | int:SUMO3 | |
| Interaction | VDR interactions | 6.30e-05 | 127 | 108 | 6 | int:VDR | |
| Interaction | GATA3 interactions | 6.70e-05 | 187 | 108 | 7 | int:GATA3 | |
| Interaction | BRD3 interactions | INTS12 ZMYND8 RSF1 MLLT10 MED1 AKAP8L RAB11FIP5 KMT2A SMARCE1 SRRM2 EVI5L | 6.97e-05 | 494 | 108 | 11 | int:BRD3 |
| Interaction | KAT2B interactions | 7.16e-05 | 256 | 108 | 8 | int:KAT2B | |
| Interaction | CEBPB interactions | SP1 DDX17 UBQLN1 RSL1D1 RSF1 KDM3B POU2F1 NUP214 MED1 POM121C RFX1 AKAP8L UBAP2L EIF4B SEC23IP SMARCE1 LSM14A SRRM2 BAG6 NUP153 | 7.38e-05 | 1443 | 108 | 20 | int:CEBPB |
| Interaction | PPARGC1A interactions | 7.92e-05 | 82 | 108 | 5 | int:PPARGC1A | |
| Interaction | GUCA2A interactions | 7.97e-05 | 16 | 108 | 3 | int:GUCA2A | |
| Interaction | HDAC1 interactions | SP1 DDX17 BCAS3 UBR4 ZMYND8 POU2F1 NUP214 RFX1 AKAP8L DENND4C ZNF608 SEC23IP KMT2A SMARCE1 ZFHX3 CAMSAP1 MED12 | 8.15e-05 | 1108 | 108 | 17 | int:HDAC1 |
| Interaction | LGR4 interactions | 8.42e-05 | 262 | 108 | 8 | int:LGR4 | |
| Interaction | SMIM2 interactions | 8.51e-05 | 3 | 108 | 2 | int:SMIM2 | |
| Interaction | DEFB115 interactions | 8.51e-05 | 3 | 108 | 2 | int:DEFB115 | |
| Interaction | HMGA1 interactions | SP1 RSF1 HIPK2 POU2F1 PIAS1 FBXO38 UBE2O KMT2A SMARCE1 CAMSAP1 | 8.56e-05 | 419 | 108 | 10 | int:HMGA1 |
| Interaction | KLF5 interactions | 8.72e-05 | 195 | 108 | 7 | int:KLF5 | |
| Interaction | PTPRH interactions | 8.88e-05 | 84 | 108 | 5 | int:PTPRH | |
| Interaction | MED23 interactions | 9.35e-05 | 266 | 108 | 8 | int:MED23 | |
| Interaction | MLLT3 interactions | 9.40e-05 | 85 | 108 | 5 | int:MLLT3 | |
| Interaction | MAPRE1 interactions | PPP1R12A NUP214 NUP42 GAS2L1 EIF4B SMARCE1 LSM14A CAMSAP1 SRRM2 POM121B NUP153 | 9.91e-05 | 514 | 108 | 11 | int:MAPRE1 |
| Interaction | GSC interactions | 1.05e-04 | 87 | 108 | 5 | int:GSC | |
| Interaction | FXR2 interactions | SPRY1 DDX17 UBAP2 RSL1D1 ZMYND8 NUP214 PHLDB1 POM121 UBAP2L LSM14A | 1.06e-04 | 430 | 108 | 10 | int:FXR2 |
| Interaction | MED17 interactions | 1.09e-04 | 202 | 108 | 7 | int:MED17 | |
| Interaction | BRCA1 interactions | SP1 DDX17 UBAP2 PCLAF RSL1D1 UBR4 OBSCN FNBP4 POU2F1 NUP214 PIAS1 FBXO38 POM121 UBAP2L SEC23IP NCOA1 MED12 NUP153 | 1.09e-04 | 1249 | 108 | 18 | int:BRCA1 |
| Interaction | CDK19 interactions | 1.11e-04 | 88 | 108 | 5 | int:CDK19 | |
| Interaction | SERPINI2 interactions | 1.15e-04 | 18 | 108 | 3 | int:SERPINI2 | |
| Interaction | PRAP1 interactions | 1.15e-04 | 18 | 108 | 3 | int:PRAP1 | |
| Interaction | NBL1 interactions | 1.15e-04 | 18 | 108 | 3 | int:NBL1 | |
| Interaction | NPY interactions | 1.15e-04 | 18 | 108 | 3 | int:NPY | |
| Interaction | MED12L interactions | 1.17e-04 | 47 | 108 | 4 | int:MED12L | |
| Interaction | TLX2 interactions | 1.17e-04 | 142 | 108 | 6 | int:TLX2 | |
| Interaction | DAXX interactions | 1.20e-04 | 353 | 108 | 9 | int:DAXX | |
| Interaction | TRIP4 interactions | 1.23e-04 | 206 | 108 | 7 | int:TRIP4 | |
| Interaction | CREM interactions | 1.23e-04 | 90 | 108 | 5 | int:CREM | |
| Interaction | NR1I3 interactions | 1.27e-04 | 48 | 108 | 4 | int:NR1I3 | |
| Interaction | HAPSTR1 interactions | UBAP2 INTS12 NUP214 MED13L AKAP8L ARID1B UBE2O MAGED2 RAB11FIP5 TAB1 SRRM2 CDH4 BAG6 NUP153 | 1.37e-04 | 829 | 108 | 14 | int:HAPSTR1 |
| Interaction | UBE2L3 interactions | 1.42e-04 | 211 | 108 | 7 | int:UBE2L3 | |
| Interaction | SMAD3 interactions | SP1 HIPK2 NUP214 ARID1B EIF4B NCOA1 RAB11FIP5 ZFHX3 NUP153 RNF111 | 1.45e-04 | 447 | 108 | 10 | int:SMAD3 |
| Interaction | NR4A1 interactions | 1.47e-04 | 212 | 108 | 7 | int:NR4A1 | |
| Interaction | ZMYND11 interactions | 1.51e-04 | 94 | 108 | 5 | int:ZMYND11 | |
| GeneFamily | CD molecules|Mucins | 1.60e-12 | 21 | 74 | 7 | 648 | |
| GeneFamily | PHD finger proteins | 1.81e-06 | 90 | 74 | 6 | 88 | |
| GeneFamily | Cyclins|Mediator complex | 9.67e-06 | 33 | 74 | 4 | 1061 | |
| GeneFamily | Ubiquilin family | 1.64e-04 | 5 | 74 | 2 | 783 | |
| GeneFamily | CD molecules|Type I classical cadherins | 1.64e-04 | 5 | 74 | 2 | 1185 | |
| GeneFamily | Nucleoporins | 3.00e-04 | 32 | 74 | 3 | 1051 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 5.84e-04 | 9 | 74 | 2 | 527 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 3.95e-03 | 23 | 74 | 2 | 523 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.66e-03 | 25 | 74 | 2 | 504 | |
| GeneFamily | Keratins, type II | 5.43e-03 | 27 | 74 | 2 | 609 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SECISBP2L SP1 DDX17 RSF1 KDM3B HIPK2 MED13L RFX1 PIAS1 ARID1B CD24 SLC9A7 SMARCE1 MLLT6 ZFHX3 LSM14A FAM199X SRRM2 AFF4 | 1.47e-09 | 807 | 112 | 19 | M16651 |
| Coexpression | NABA_ECM_AFFILIATED | 8.72e-06 | 170 | 112 | 7 | M5880 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN | 2.42e-05 | 199 | 112 | 7 | M9504 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.77e-05 | 137 | 112 | 6 | M39241 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SECISBP2L HIPK1 FNBP4 POM121C POM121 UBAP2L ATXN7 RNF10 NCOA1 MED13 NUP153 AFF4 | 3.50e-05 | 680 | 112 | 12 | M41089 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SECISBP2L NRG1 RSL1D1 DLGAP4 RSF1 FNBP4 POU2F1 MED13L AKAP8L DENND4C FBXO38 NCOA1 AFF4 | 5.03e-05 | 822 | 112 | 13 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 5.54e-05 | 155 | 112 | 6 | M39246 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 5.77e-05 | 49 | 112 | 4 | M17173 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 6.76e-05 | 51 | 112 | 4 | MM647 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L NRG1 DDX17 PPP1R12A ZMYND8 KDM3B MED13L MED1 NCOA1 ZFHX3 CDH2 MED13 NUP153 | 7.58e-05 | 856 | 112 | 13 | M4500 |
| Coexpression | BENPORATH_NANOG_TARGETS | SPRY1 DDX17 UBAP2 INTS12 PCLAF POU2F1 MLLT10 RFX1 GAS2L1 ARID1B EIF4B CDH2 BAG6 MED12 | 8.27e-05 | 988 | 112 | 14 | M6616 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | EYA4 PCLAF RSL1D1 OBSCN FNBP4 KDM3B NUP214 MED1 ONECUT1 TULP3 POM121 UBAP2L EIF4B SEC23IP LSM14A TAB1 NUP153 | 8.77e-05 | 1394 | 112 | 17 | M9585 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | UBQLN2 HIPK1 KDM3B DENND4C SEC23IP SLTM NCOA1 LSM14A CAMSAP1 | 9.63e-05 | 429 | 112 | 9 | M29 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.95e-09 | 166 | 112 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.19e-07 | 176 | 112 | 7 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-06 | 170 | 112 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.58e-06 | 176 | 112 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.77e-06 | 182 | 112 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.77e-06 | 182 | 112 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 6.98e-06 | 183 | 112 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.18e-06 | 192 | 112 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 200 | 112 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.68e-05 | 126 | 112 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 78 | 112 | 4 | 5b45aacaff2a2b98c4ef8e7ac51ad482a69a1d8b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 78 | 112 | 4 | afed2f358c8a33889931bc5ad8cb24f92323e6f8 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 6.65e-05 | 168 | 112 | 5 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 170 | 112 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.43e-05 | 172 | 112 | 5 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.63e-05 | 173 | 112 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.28e-05 | 176 | 112 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 179 | 112 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.96e-05 | 179 | 112 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.20e-05 | 180 | 112 | 5 | d1beaf1f106c7efaeaf61f29742d0a7310a83916 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.20e-05 | 180 | 112 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.20e-05 | 180 | 112 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.20e-05 | 180 | 112 | 5 | 156b988b71f6dcf3117c1e5f4625632cb97e54f2 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.44e-05 | 181 | 112 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.02e-04 | 184 | 112 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 185 | 112 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 187 | 112 | 5 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-04 | 188 | 112 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.13e-04 | 188 | 112 | 5 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.16e-04 | 189 | 112 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.19e-04 | 190 | 112 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.25e-04 | 192 | 112 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 192 | 112 | 5 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 192 | 112 | 5 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 193 | 112 | 5 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 193 | 112 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.28e-04 | 193 | 112 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 193 | 112 | 5 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.28e-04 | 193 | 112 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 194 | 112 | 5 | d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.31e-04 | 194 | 112 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.31e-04 | 194 | 112 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 195 | 112 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 195 | 112 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.37e-04 | 196 | 112 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 196 | 112 | 5 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-04 | 197 | 112 | 5 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.40e-04 | 197 | 112 | 5 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.40e-04 | 197 | 112 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 198 | 112 | 5 | 2ae9564da9913510141994262f3739eb095e0a68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.47e-04 | 199 | 112 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-04 | 199 | 112 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-04 | 199 | 112 | 5 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.51e-04 | 200 | 112 | 5 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-04 | 200 | 112 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-04 | 200 | 112 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.51e-04 | 200 | 112 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | SECISBP2L DDX17 HIPK1 PPP1R12A ZMYND8 MED13L SEC23IP LRP6 KMT2A SRRM2 | 1.58e-08 | 183 | 107 | 10 | 1709_DN |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.01e-06 | 178 | 107 | 8 | 3998_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.40e-06 | 191 | 107 | 8 | 4279_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 4715_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 7138_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 4.43e-06 | 198 | 107 | 8 | 7266_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; HL60; HT_HG-U133A | 4.60e-06 | 199 | 107 | 8 | 2331_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.99e-05 | 176 | 107 | 7 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.14e-05 | 178 | 107 | 7 | 7245_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.30e-05 | 180 | 107 | 7 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.47e-05 | 182 | 107 | 7 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.94e-05 | 187 | 107 | 7 | 4302_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 3.15e-05 | 189 | 107 | 7 | 6649_DN | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.26e-05 | 190 | 107 | 7 | 3848_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.37e-05 | 191 | 107 | 7 | 3830_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.60e-05 | 193 | 107 | 7 | 3857_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.60e-05 | 193 | 107 | 7 | 3845_UP | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.72e-05 | 194 | 107 | 7 | 1205_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.72e-05 | 194 | 107 | 7 | 4361_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.84e-05 | 195 | 107 | 7 | 4019_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 2065_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 3568_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 4335_UP | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 6563_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 1806_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 1680_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 5493_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 2054_DN | |
| Drug | quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.23e-05 | 198 | 107 | 7 | 917_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 5353_DN | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 7247_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 3017_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 4.51e-05 | 200 | 107 | 7 | 5782_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.69e-04 | 173 | 107 | 6 | 4237_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.91e-04 | 177 | 107 | 6 | 985_DN | |
| Drug | 2,4,6-TCA | 2.17e-04 | 5 | 107 | 2 | CID000012471 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.23e-04 | 182 | 107 | 6 | 1951_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 2.23e-04 | 182 | 107 | 6 | 6896_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.43e-04 | 185 | 107 | 6 | 1114_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 185 | 107 | 6 | 1673_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.65e-04 | 188 | 107 | 6 | 5116_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.73e-04 | 189 | 107 | 6 | 4271_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 2.73e-04 | 189 | 107 | 6 | 1206_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 2.73e-04 | 189 | 107 | 6 | 7074_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.81e-04 | 190 | 107 | 6 | 4507_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.81e-04 | 190 | 107 | 6 | 4322_DN | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.89e-04 | 191 | 107 | 6 | 5957_DN | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.89e-04 | 191 | 107 | 6 | 2227_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.89e-04 | 191 | 107 | 6 | 7220_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.97e-04 | 192 | 107 | 6 | 5058_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.05e-04 | 193 | 107 | 6 | 3906_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 3.05e-04 | 193 | 107 | 6 | 1982_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 1670_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 1180_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HG-U133A | 3.14e-04 | 194 | 107 | 6 | 1935_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 4284_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 6763_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 1699_DN | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 6242_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 6339_DN | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 1478_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 1269_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.22e-04 | 195 | 107 | 6 | 919_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 2761_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 3862_UP | |
| Drug | SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 7060_UP | |
| Drug | butamben | 3.24e-04 | 6 | 107 | 2 | ctd:C004605 | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5063_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 7224_DN | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HG-U133A | 3.31e-04 | 196 | 107 | 6 | 1892_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A | 3.31e-04 | 196 | 107 | 6 | 1567_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 3567_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 1685_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A | 3.31e-04 | 196 | 107 | 6 | 1445_DN | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3319_DN | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; HL60; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 2181_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 5087_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3439_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3568_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 3.40e-04 | 197 | 107 | 6 | 1941_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 7478_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; HL60; HG-U133A | 3.40e-04 | 197 | 107 | 6 | 1774_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 2326_DN | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 6017_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 7166_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 3396_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 3.50e-04 | 198 | 107 | 6 | 1609_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 3.50e-04 | 198 | 107 | 6 | 1997_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 4353_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 3112_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 7190_DN | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 5514_UP | |
| Drug | PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 7076_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 2217_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; HL60; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 2979_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 6080_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; PC3; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 6608_DN | |
| Drug | Iocetamic acid [16034-77-8]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 3022_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 5304_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 4592_DN | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 4.12e-05 | 3 | 110 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.37e-04 | 5 | 110 | 2 | C3281201 | |
| Disease | obesity (implicated_via_orthology) | 1.59e-04 | 215 | 110 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Hirschsprung Disease | 2.10e-04 | 31 | 110 | 3 | C0019569 | |
| Disease | Asperger syndrome | 2.86e-04 | 7 | 110 | 2 | EFO_0003757 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 2.86e-04 | 7 | 110 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | Abnormality of the eye | 2.86e-04 | 7 | 110 | 2 | C4316870 | |
| Disease | creatinine measurement | NRG1 EYA4 BCAS3 OBSCN MED1 FRY ATXN7 NFE2L1 EIF4B ZFHX3 ALDOB SHISA3 | 3.43e-04 | 995 | 110 | 12 | EFO_0004518 |
| Disease | Gastrointestinal Stromal Sarcoma | 7.25e-04 | 47 | 110 | 3 | C3179349 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 7.41e-04 | 11 | 110 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | Gastrointestinal Stromal Tumors | 8.70e-04 | 50 | 110 | 3 | C0238198 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 8.87e-04 | 12 | 110 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 8.87e-04 | 12 | 110 | 2 | DOID:674 (is_implicated_in) | |
| Disease | sleep apnea measurement | 9.50e-04 | 116 | 110 | 4 | EFO_0007817 | |
| Disease | Abnormality of refraction | 9.51e-04 | 673 | 110 | 9 | HP_0000539 | |
| Disease | Coffin-Siris syndrome | 1.05e-03 | 13 | 110 | 2 | C0265338 | |
| Disease | fructose measurement | 1.05e-03 | 13 | 110 | 2 | EFO_0010477 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.25e-03 | 125 | 110 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.25e-03 | 125 | 110 | 4 | C1879321 | |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 110 | 7 | C3714756 | |
| Disease | coronary artery calcification | 1.51e-03 | 450 | 110 | 7 | EFO_0004723 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 1.60e-03 | 16 | 110 | 2 | EFO_0020346 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.78e-03 | 64 | 110 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Acute myeloid leukemia | 1.81e-03 | 17 | 110 | 2 | cv:C0023467 | |
| Disease | major depressive disorder (is_marker_for) | 1.81e-03 | 17 | 110 | 2 | DOID:1470 (is_marker_for) | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.81e-03 | 17 | 110 | 2 | 601626 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.81e-03 | 17 | 110 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | ONECUT2 NRG1 EYA4 OBSCN MUC19 NUP214 MLLT10 KRT79 POM121C NFE2L1 | 2.06e-03 | 904 | 110 | 10 | EFO_0004736 |
| Disease | neuroticism measurement | DOCK3 POU6F2 UBQLN2 TRO ZMYND8 FNBP4 HIPK2 MAGED2 KMT2A BAG6 | 2.14e-03 | 909 | 110 | 10 | EFO_0007660 |
| Disease | Malignant neoplasm of breast | NRG1 UBR4 OBSCN POU2F1 NUP214 SIX4 ARID1B MAGED2 NCOA1 CDH2 MED12 | 2.26e-03 | 1074 | 110 | 11 | C0006142 |
| Disease | Meningioma | 2.26e-03 | 19 | 110 | 2 | C0025286 | |
| Disease | osteoporosis | 2.59e-03 | 73 | 110 | 3 | EFO_0003882 | |
| Disease | glaucoma | 2.68e-03 | 154 | 110 | 4 | MONDO_0005041 | |
| Disease | non-small cell lung carcinoma | 2.80e-03 | 75 | 110 | 3 | EFO_0003060 | |
| Disease | testosterone measurement | DOCK3 UBQLN2 DLGAP4 GDF6 FNBP4 ONECUT1 FBXO38 ARID1B SEC23IP NCOA1 ZFHX3 MED12 | 2.87e-03 | 1275 | 110 | 12 | EFO_0004908 |
| Disease | Etat Marbre | 3.31e-03 | 23 | 110 | 2 | C0266487 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 3.60e-03 | 24 | 110 | 2 | OBA_2045136 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.60e-03 | 24 | 110 | 2 | DOID:12894 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSSLVSSSSASSNLS | 66 | Q96CN4 | |
| SSGKGVSSFTSASSS | 316 | P55198 | |
| TGTSSNSSQSTSNSG | 31 | P25063 | |
| ASASAGTTNTATTAG | 571 | P46379 | |
| TGSSGAASTQSLFTA | 346 | P05062 | |
| GSTQTYASQSSSEGS | 726 | Q8TC27 | |
| LSSAVSASGSTSSQG | 766 | Q8NFD5 | |
| NAKSSGNSSSSGSGS | 6 | Q12797 | |
| SSSSGSSISSARSSG | 71 | Q15517 | |
| SSSSQTSGVSSSGQS | 196 | Q15517 | |
| STIGGTAAQATTSSS | 16 | A6NGY3 | |
| TAAQATTSSSATSGS | 21 | A6NGY3 | |
| SIETLSNSSGSTSGS | 886 | Q9H6U6 | |
| TQSGSSLSLASAATT | 1396 | Q5T5Y3 | |
| SQSGLSNSSDSLDSS | 601 | Q9Y2H0 | |
| TNANTSASGSASADS | 76 | Q9ULX6 | |
| SGASSASASGSSVTI | 1071 | Q9UHB7 | |
| GSTATASSTQATAGT | 3736 | Q9HC84 | |
| STSLNSTFGSTNLTG | 401 | Q14494 | |
| STSNSGNETSGSSTI | 41 | Q86U06 | |
| TQSNTSLGSDSTLSS | 246 | Q9BXF6 | |
| TVISGNSSSASVSSS | 271 | Q96CB8 | |
| NSSSASVSSSVTSGL | 276 | Q96CB8 | |
| EGANTSSSTSTSTTG | 161 | Q02297 | |
| ATSQGTFTLDSSSTA | 9376 | Q8WXI7 | |
| KSSSNVTSTSGHSSG | 1001 | Q9H2X6 | |
| ISQISTTSSSGFSGS | 1596 | Q71F56 | |
| AQESGSASTGASTST | 541 | Q9UNF1 | |
| SASTGASTSTNNSAS | 546 | Q9UNF1 | |
| ANTGSSVISSGASTA | 31 | Q5SSG8 | |
| SVISSGASTATNSGS | 36 | Q5SSG8 | |
| GASTATNSGSSVTSS | 41 | Q5SSG8 | |
| TNSGSSVTSSGVSTA | 46 | Q5SSG8 | |
| GAGTATNSESSTTSS | 221 | Q5SSG8 | |
| GAGTATNSESSTTSS | 251 | Q5SSG8 | |
| TNSESSTTSSGAGTA | 256 | Q5SSG8 | |
| STTSSGAGTATNSES | 261 | Q5SSG8 | |
| GAGTATNSESSTVSS | 266 | Q5SSG8 | |
| STTSSGASTATNSGS | 351 | Q5SSG8 | |
| GASTATNSGSSTTSS | 356 | Q5SSG8 | |
| TNSGSSTTSSGTSTA | 361 | Q5SSG8 | |
| STTSSGANTATNSGS | 426 | Q5SSG8 | |
| GANTATNSGSSVTSA | 431 | Q5SSG8 | |
| TNSGSSVTSAGSGTA | 436 | Q5SSG8 | |
| STAGSENTTVSSAGS | 321 | E2RYF6 | |
| SSGSAATSTFQSSQT | 91 | Q86Z02 | |
| TSFSSVTVSRSSGSG | 31 | Q5XKE5 | |
| SSSTAGSSAAAATSA | 61 | Q86X51 | |
| SDSGGSSSSSSSSIN | 111 | Q969W3 | |
| STSGVSGASASASSS | 271 | Q6PEV8 | |
| SSASSSGSSVGNSAS | 291 | Q6PEV8 | |
| SGSSNSEATTFSGIT | 7761 | Q7Z5P9 | |
| AATTGTGQTTFTSST | 591 | Q02505 | |
| KSSSSVSSQGSVASS | 476 | Q9H4H8 | |
| DEGSSNSGNSSSSSS | 446 | Q9UBC0 | |
| STSGQSSSSGQHDSS | 846 | Q86YZ3 | |
| SSSSGQHDSSSGQSS | 851 | Q86YZ3 | |
| QDDLSTGGSSSTSST | 486 | O95948 | |
| SFASQASGSSSSATT | 651 | Q7LBC6 | |
| TGASSSSSSSTKGTY | 1466 | O75581 | |
| STSGSVFGAASSTSS | 1766 | P35658 | |
| SSLTSFGTETSNSGT | 141 | Q8ND56 | |
| QQSAETGSSSGSTAS | 1391 | Q93074 | |
| SSSGGVLSASSSSSK | 206 | O15265 | |
| LGSSTSATNSTSVSS | 26 | Q15004 | |
| VASASGAASTTTTAS | 726 | P14859 | |
| SLDSDQSSGSTTSGS | 1726 | O95248 | |
| SDTFGNSSISTSLSA | 361 | O15504 | |
| SGFGATTQTASSGSS | 1051 | A8CG34 | |
| TTQTASSGSSSSVFG | 1056 | A8CG34 | |
| SGFGATTQTASSGSS | 656 | A6NF01 | |
| TTQTASSGSSSSVFG | 661 | A6NF01 | |
| TGGSSSSSSSSDNEL | 6786 | Q5VST9 | |
| SGFGATTQTASSGSS | 1071 | Q96HA1 | |
| TTQTASSGSSSSVFG | 1076 | Q96HA1 | |
| STTASTVGNSSSHNT | 706 | Q6PIJ6 | |
| AGSSAFSQSSGTLAS | 366 | P0CG12 | |
| SNLSSTSVTTNGTGG | 56 | O95677 | |
| SNSTLSGSASSGVSS | 1881 | Q8IZD9 | |
| SGSASSGVSSLSESN | 1886 | Q8IZD9 | |
| CSSSSSSSSLSVLGG | 561 | Q99501 | |
| TAGSVSSLNSSSSGD | 876 | P55283 | |
| LTQSNTSLGSSSSSG | 1426 | Q5VZ89 | |
| LTSGSVSGLASSSSV | 3326 | Q03164 | |
| GASSTTSTGRSSQSS | 661 | Q92841 | |
| ASSKASAAASGTTSS | 1521 | Q5TBA9 | |
| SAAASGTTSSSNTVV | 1526 | Q5TBA9 | |
| SSSTSSSISLGGSSG | 1756 | Q5TBA9 | |
| TSTGALATSSSSLGF | 291 | D6RIA3 | |
| SSAQTSAAGATATTS | 766 | Q9ULU4 | |
| DNSTASASLASNGTS | 1396 | Q96T23 | |
| SGFSQLSAATSSSSS | 671 | O43304 | |
| TAGSLSSLNSSSSGG | 866 | P19022 | |
| SQYTSSGSVSSSGSK | 1081 | Q15648 | |
| GSESSQTGTSTTSSR | 421 | P23588 | |
| TGSAANTATGTTSTN | 61 | Q685J3 | |
| SSSSSSSGQLVDFTL | 396 | Q8ND04 | |
| ASISSSSSSAELGST | 26 | Q6KF10 | |
| GSQSLSSGAVATTTS | 2471 | Q9UQ35 | |
| GTSDSNTGSESNSAT | 381 | Q969G3 | |
| TNTHTQSSSSSSDGG | 446 | Q15750 | |
| AATSTLSSSTSNGTD | 181 | Q8N3X1 | |
| SGSSSGNTASLTITG | 81 | P01714 | |
| VASSTSTGAGASNSS | 366 | P22670 | |
| TGTSNSASANSSGGS | 661 | Q15788 | |
| SSSSSSSSALSVGQL | 451 | P78424 | |
| GAVDSGSSSSSSSSS | 1841 | Q8NFP9 | |
| GSSSSSSSSSFVNGA | 1846 | Q8NFP9 | |
| STSSTSGSSGSSTKN | 371 | Q9NWH9 | |
| QGNISVSSSTSDGST | 516 | Q9UIU6 | |
| QSSTATSSSSTGGSI | 161 | A0PJX4 | |
| TGSTTSATSAGKSTA | 926 | Q93073 | |
| TSGASNTTQTSSLST | 761 | Q01974 | |
| SSSGTNLLFSSSATE | 16 | Q9Y6Y8 | |
| ASTSSSSSSNLNSGV | 1536 | Q9UHV7 | |
| GSSSGSNSSLVSSNS | 606 | O75925 | |
| TSSLSSSSNSGSYKG | 31 | O15079 | |
| SQARSSSTGSSSSTG | 36 | P08047 | |
| TSSVASAAGSITSSS | 501 | P55197 | |
| SKVNSVGSSSTSSSG | 536 | Q9UPZ9 | |
| FSTAATSVSSSASSG | 741 | Q5T6F2 | |
| SVSSSLNSGSSLGLS | 751 | Q14157 | |
| SATLTSNSTTGTSIG | 441 | Q6ZNA4 | |
| NTASISFGGTLSTSS | 771 | Q12816 | |
| SFGGTLSTSSSFSSA | 776 | Q12816 | |
| GTLSTSVSFGGSSST | 931 | Q12816 | |
| GSSSTSANFGGTLST | 941 | Q12816 | |
| SASLSSAAATGTSTS | 6 | O76021 | |
| DKNSGSNSSSASSGS | 16 | Q8N5U6 | |
| TGSTASGTSGQSTTA | 346 | Q9UMX0 | |
| SSASSTTSSQSGSGT | 496 | Q9C0C9 | |
| LSRSTSTGSAASSGS | 111 | O43609 | |
| STGSAASSGSNSSAS | 116 | O43609 | |
| ASSGSNSSASSEQGL | 121 | O43609 | |
| SSSAFGNTAESSTSQ | 1236 | P49790 | |
| GSSSSSSQLSVATLG | 986 | Q86UU1 | |
| TSSSVSSTSATINGG | 781 | O15195 | |
| NSNSTSTSTSAATAG | 166 | Q9ULD9 | |
| TSTGSGSGNSSSNAT | 336 | Q9UHD9 | |
| TANGSSSSHTASTSL | 671 | Q96T83 | |
| LAASSGSSSASSSSA | 3336 | Q5T4S7 | |
| NSASSQNSTDTGTSG | 156 | O75386 | |
| GTASTSSNSASSFVV | 546 | Q15911 | |
| SNGTGNSSSISLSSS | 1636 | Q15911 | |
| GSGSSVKFVSTTSSS | 531 | O95678 | |
| ITTGSSSAGTQSSTS | 596 | O14974 |